Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XPECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XPECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XPEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XPEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XPENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DN.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DN.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DN.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.23ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.23ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.23EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.23EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.30EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.30ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.30ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.30EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.30EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.1.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.1.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.1.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.87EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.87ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.87ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used